Vertex partners with Entrada on new approach for muscle dystrophy treatment
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. have formed a global partnership to find and develop treatments for myotonic dystrophy type 1 (DM1), a […]
Vertex partners with Entrada on new approach for muscle dystrophy treatment Read More »